Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00826787 · ClinicalTrials.gov registry record · NA
Bioequivalency Study of Levetiracetam 750 mg Tablets Under Fed Conditions
A NA study, sponsored by Roxane Laboratories.
- Completed
- Registry status
- NA
- Development phase
- 29
- Enrollment target
NCT00826787: Completed NA study, sponsored by Roxane Laboratories.
NCT00826787 is a NA study that has completed, run by Roxane Laboratories. The registered enrollment target is 29 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00826787, a NA study, has completed, sponsored by Roxane Laboratories.
- COMPLETED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
Study Summary
The objective of this study was to prove the bioequivalence of Levetiracetam 750 mg Tablets under fed conditions
Interventions
- DRUG Levetiracetam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2005-08 |
| Est. Completion | 2005-08 |
| Phase | NA |
What the finished NCT00826787 record still lists
NCT00826787 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Levetiracetam is the first listed.
NCT00826787 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00826787 about?
NCT00826787 is a clinical study titled "Bioequivalency Study of Levetiracetam 750 mg Tablets Under Fed Conditions". The objective of this study was to prove the bioequivalence of Levetiracetam 750 mg Tablets under fed conditions
What is the current status of trial NCT00826787?
This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2005-08. Estimated completion is 2005-08.
What interventions are being tested in trial NCT00826787?
The interventions under investigation include: Levetiracetam (DRUG).
Who is sponsoring clinical trial NCT00826787?
This trial is sponsored by Roxane Laboratories, which has 93 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00826787's enrollment target sits among peer trials
29 1702nd of 2000 higher than 297 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia